Legalization of Psychedelics for Medical Use

The article discusses the push to legalize psychedelics, particularly MDMA, for medical use in treating PTSD. Despite promising results in studies, the FDA rejected the proposal from MAPS's pharmaceutical arm, leading to setbacks in the psychedelic movement. The rejection was influenced by concerns over the safety and efficacy of MDMA, including issues with research methodology and allegations of sexual misconduct. Critics argue that the psychedelic culture prioritizes recreational use over medical benefits, leading to a lack of rigorous clinical trials and protocols.

FDA Recall of Clonazepam due to Mislabeling

FDA recalls Clonazepam due to mislabeling, posing 'life-threatening' risks. Endo Inc. issues voluntary recall of 16 lots of Clonazepam Orally Disintegrating Tablets. Labeling error could lead to significant side effects including respiratory depression.

Baby Formula Recall Due to Excessive Vitamin D Levels

Approximately 16,500 cans of baby formula have been voluntarily recalled due to excessive levels of vitamin D, which could result in health complications for vulnerable infants. The affected products were shipped to CVS and H-E-B stores in 12 states.

The Dangers of Panera Bread's Charged Lemonade

Sarah Katz, a 21-year-old college student with an underlying heart condition, died from cardiac arrest after consuming Panera Bread's Charged Lemonade, which contained high levels of caffeine. Her parents are suing Panera for negligence. Other lawsuits have been filed due to health issues caused by the drink. The FDA recommends a daily caffeine limit of 400mg.

FDA rejection of MDMA as a treatment for PTSD

FDA rejects MDMA as a treatment for PTSD despite advocacy from veteran organizations. Another Phase 3 trial is requested to confirm safety and efficacy. Companies plan to appeal the decision.

FDA considering MDMA-AT for treating PTSD

FDA is considering approving MDMA-AT for treating PTSD, a decision expected by Aug. 11. Veterans have reported positive effects with MDMA therapy. Lawmakers and veterans are advocating for FDA approval despite some concerns from FDA advisory committee.

FDA Approval of Jemperli for Endometrial Cancer Treatment

The FDA has approved a new immunotherapy drug called Jemperli for certain adult patients with endometrial cancer. This is the third FDA approval this year for immunotherapy in endometrial cancer, showing improved outcomes for patients.

New Blood Test for Colorectal Cancer Screening

FDA approves new blood test for colorectal cancer screening, offering a simpler and less invasive option compared to colonoscopy. The test has an 83% sensitivity for detecting colorectal cancer.

FDA Proposal Delayed to Ban Formaldehyde in Hair Products

The FDA has delayed the proposal to ban formaldehyde in hair relaxers and straighteners, which poses health risks, especially to Black women. The ban is expected to protect the health and safety of communities of color, but it has been pushed back multiple times. Formaldehyde is a toxic gas linked to hormone-related cancer and other health issues.

The Controversy Surrounding Tianeptine

Tianeptine, once prescribed for depression in many countries, is now being sold in products like Neptune's Fix and Za Za, posing serious health risks. The drug, not FDA approved, has led to a spike in overdose cases and dependency issues. Despite being banned in several states, tianeptine is available online and in stores, causing concern due to its opioid-like effects and potential for addiction.

Risks of Nicotine Pouches like Zyn

The use of nicotine pouches like Zyn has soared in popularity, leading to addiction and health issues for some users. Medical experts are concerned about the impact on both adults and youth, with potential risks including gastrointestinal problems, gum issues, and addiction. The FDA is reviewing the marketing applications for these products amidst concerns about appeal to underage individuals.

FDA Recall of Potassium Chloride Capsules

FDA announces recall of potassium chloride capsules due to failed dissolution, which could lead to heart attacks. Two brands are affected, Glenmark Pharmaceuticals and American Health Packaging.

Alleged Pressure on FDA for COVID-19 Vaccine Approval

The Biden administration allegedly pressured FDA officials to expedite the COVID-19 vaccine for children before adequate testing was completed, leading to concerns about vaccine safety. Fired FDA officials claimed they were removed for wanting more time for testing. Testimonies during a House Judiciary subcommittee hearing highlighted vaccine injuries and loss of trust in the government's handling of COVID-19 vaccines.

Food Safety Labeling Issue at Bimbo Bakeries USA

U.S. federal food safety regulators warn Bimbo Bakeries USA to stop labeling products as containing allergens when they do not. The company listed ingredients like sesame or tree nuts on labels even when not present in the food. Advocates say this is harmful for the 33 million Americans with food allergies.

Supreme Court ruling on abortion pill access

Supreme Court rejects challenge to abortion pill, affirming widespread availability of mifepristone. President Biden emphasizes the fight for reproductive freedom continues despite the ruling. Anti-abortion doctors lacked legal standing to sue FDA over access to the pill.

Supreme Court Decision on Abortion Pill Regulation

Pro-life organizations are disappointed by the Supreme Court's decision on the abortion pill, stating concerns about the health and safety of women. The decision did not address the legality of FDA's actions but emphasized standing issues. Various pro-life advocates expressed disappointment and vowed to continue fighting against the deregulation of mifepristone.

Supreme Court Decision on FDA's Rules on Abortion Medication

The Supreme Court upheld the FDA's rules on abortion medication, ensuring continued access to mifepristone for medication abortions and miscarriage care. Doctors opposing abortion lost their legal challenge. More challenges may arise in the future, but for now, mifepristone remains available up to 10 weeks of pregnancy.

Supreme Court ruling on pro-life doctors and Biden's abortion pill mandate

The Supreme Court unanimously held that pro-life doctors lack standing to challenge Biden's abortion pill mandate, paving the way for Republican-led states to challenge it. The decision is seen as a win for religious liberty, affirming that pro-life doctors cannot be forced to participate in abortion.

Supreme Court ruling on abortion drug mifepristone

The Supreme Court ruled in favor of allowing full access to abortion drug mifepristone, rejecting a challenge to the FDA's approval process. The decision was a victory for the Biden administration and abortion rights supporters.

Alzheimer's Drug Donanemab

An experimental Alzheimer’s drug, donanemab, was endorsed by a U.S. Food and Drug Administration advisory panel. The drug is designed to treat symptoms of early Alzheimer’s disease and has shown promising results in clinical trials.

FDA Warning on Contaminated Shellfish in Oregon and Washington States

The U.S. FDA warns against consuming shellfish from Oregon and Washington states due to contamination with paralytic shellfish poisoning toxins. At least 31 people in Oregon have been sickened. The toxin is produced by algae and can cause numbness, vomiting, diarrhea, and other severe symptoms. Cooking or freezing contaminated shellfish does not make them safe to eat.

FDA Warning About Diamond Shruumz Chocolate Bars

The FDA is warning consumers about Diamond Shruumz mushroom-infused chocolate bars that have reportedly caused severe reactions in some people. The bars are marketed as providing a relaxed euphoric experience without psilocybin, but have led to seizures, vomiting, and hospitalizations in consumers.

FDA Restrictions on Gay Men Donating Tissue

Advocates are pushing for the FDA to update rules on gay men donating tissue, particularly corneas, to align with guidelines for the rest of the human body. The current restrictions, based on outdated concerns about HIV transmission, are seen as unnecessary and discriminatory.

Neuralink's Brain Implants and FDA Approval

Neuralink faces challenges as tiny wires in brain implants retract, potentially affecting brain signals; FDA aware of issue since animal testing; company aims to restore implant's function by making changes to algorithm; company seeks to design threads for seamless removal; company faces safety concerns and complications during trials; researchers debate causes of inflammation in brain; FDA issues notice for Trilogy EVO Continuous Ventilators

FDA Misses Deadline for Formaldehyde Ban in Hair Products

The Food and Drug Administration missed its own deadline to propose a ban on formaldehyde in hair relaxers and straighteners, raising concerns about public health. Formaldehyde is a highly toxic gas linked to cancer and other health risks, especially for Black women.

Counterfeit Botox Injections in the U.S.

CDC and FDA are investigating reports of patients in nearly a dozen U.S. states being injected with counterfeit Botox, leading to harmful reactions and hospitalizations. Public health authorities warn against receiving injections from untrained individuals or in non-health care settings. Consumers are urged to ensure they are receiving genuine Botox from licensed providers to avoid serious health risks.

Shortage of weight-loss drug Zepbound

Shortage of weight-loss drug Zepbound driving customers to extremes, but relief may be near. FDA lists Zepbound as in short supply, leading to challenges in obtaining the medication. Customers are going to great lengths to secure the drug, with some sharing their experiences on Reddit. Shortage expected to be resolved by end of April.

Supreme Court case on FDA regulations for mifepristone

The Supreme Court heard oral arguments in the case FDA v. Alliance for Hippocratic Medicine, which involves the FDA's changes to safety restrictions for mifepristone, the first drug in a two-drug abortion regimen. The case questions the FDA's decisions regarding gestational age, reporting complications, and allowing mifepristone to be sent via mail. The lawsuit alleges that the FDA's actions violated federal laws and endangered women's health.

Controversy over FDA's Handling of Abortion Pill

Vice President Harris visited a Planned Parenthood abortion facility in Minnesota, sparking controversy over the FDA's handling of the abortion pill mifepristone, which is at the center of a high-stakes Supreme Court case.

Supreme Court's Potential Decision on Abortion Pill Mifepristone Challenge

The Supreme Court appears likely to reject a challenge to the abortion pill mifepristone, focusing on legal standing rather than the FDA's decisions. The case is a major test for the conservative-majority court after overturning Roe v. Wade.

Supreme Court's Potential Dismissal of Challenge Against FDA's Abortion Drug Regulations

The Supreme Court appears ready to dismiss a challenge against the FDA's relaxed requirements for dispensing an abortion drug, maintaining current rules and allowing access in most of the country. Former President Donald Trump discusses 'common sense' on 'MediaBuzz' and mentions the three exceptions on abortions.

Supreme Court's Consideration of Restricting Abortion Medication Access

The Supreme Court's anti-abortion majority is considering restricting women's access to abortion medication, which could impact states where abortion is legal. Conservative judges in Texas are pushing to impose stricter rules on abortion pills. The case involves a group of doctors challenging the FDA's approval of mifepristone. Abortion-rights advocates are concerned about the potential implications of the case.

Abortion Pills Regulation

Conservative Christian group is trying to shut down access to abortion pills nationwide by challenging FDA's regulation of mifepristone, a drug used in 63% of US abortions. The case could lay the groundwork for a de facto nationwide abortion ban.

The Wellness Company promoting ivermectin and Contagion Emergency Kits for COVID-19 treatment

The Wellness Company promotes the use of ivermectin and other drugs for COVID-19 treatment, advocating against FDA restrictions. They offer a Contagion Emergency Kit with prescription-only medications. The company claims these kits are essential for emergency preparedness.

Supreme Court Case on Mifepristone Regulations

The Supreme Court is set to hear oral arguments in a case that could impact how mifepristone is used in the U.S. The case involves the FDA's changes to safety restrictions for mifepristone, including allowing mail delivery and telemedicine prescriptions. The Alliance Defending Freedom filed a lawsuit against the FDA, alleging safety concerns. The case challenges FDA actions since the approval of mifepristone in 2000.

Supreme Court's Decision on Abortion Pill Access

The Supreme Court is set to decide on a high-stakes appeal regarding nationwide access to the abortion pill, mifepristone. The case has legal, social, and political implications, with abortion rights groups and anti-abortion organizations presenting contrasting arguments.

Over-the-Counter Birth Control Pill Opill Now Available Online in the US

The first over-the-counter birth control pill, Opill, is now available for purchase online in the United States. It is 93% effective, priced from $19.99 for a one-month supply, and does not have age restrictions. Opill must be taken daily for it to be effective and is generally safe for most people who could get pregnant. Side effects include irregular bleeding, headaches, and nausea.

Crackdown on Illegal Sale of Vaping Products

Legislation aimed at cracking down on the illegal sale of electronic cigarettes to young people and keeping unauthorized vaping products out of stores won passage in the Kentucky House. The bill would require businesses to acknowledge their involvement in tobacco product sales, with fines for violations.

Breakthrough Therapy Status for LSD Formulation to Treat Generalized Anxiety Disorder

A clinical trial's positive results led to an LSD formulation receiving breakthrough therapy status from the FDA for treating generalized anxiety disorder. The drug by Mind Medicine Inc. showed promising efficacy and safety in phase 2b trials.

FDA Advisory on Cinnamon Products Containing Lead

The FDA issued an advisory for six brands of cinnamon sold in U.S. discount stores due to elevated levels of lead. No illnesses have been linked to the products, but consumers are advised to discard the impacted cinnamon products.

Abortion Debate and Big Tech Censorship

President Biden appears to support abortion for all three trimesters of pregnancy, Republican attorneys general demand YouTube remove a "misleading" context disclaimer on a pro-life video, AGs criticize YouTube for spreading false information about chemical abortions, and reference a Supreme Court case on abortion pill challenge.

Over-the-Counter Birth Control Pill Opill Approved in the U.S.

The first over-the-counter birth control pill, Opill, has been approved in the United States and is now available at major retailers and pharmacies for around $19.99 per month. Opill contains progestin and does not require a prescription, making it easier for women and teenagers to access contraceptive medication.

Pharmacies Selling Abortion Drugs

CVS and Walgreens are set to begin selling abortion drugs following the FDA's rollback of safety restrictions for mifepristone. The move comes ahead of a Supreme Court battle challenging the FDA's decision. The drugs will be dispensed with a prescription in select locations.

Misinformation about COVID-19 Vaccines and Blood Donation

Social media posts falsely claim that COVID-19 vaccines are unsafe based on a misinterpretation of a question asked by the American Red Cross about blood donation eligibility. The Red Cross and FDA affirm that vaccinated individuals can donate blood safely, as long as they are feeling well.

Dispensing of Mifepristone by CVS and Walgreens

CVS and Walgreens have received federal certification to dispense the drug mifepristone for medication abortions, expanding access to the drug in states where it is legal. This comes as many states are imposing restrictions on abortion procedures.

FDA Inspection Findings at Neuralink

FDA inspectors found problems with record keeping and quality controls for animal experiments at Elon Musk's Neuralink, raising concerns about attention to detail and quality assurance practices.

COVID-19 Vaccine Safety Monitoring Systems

Despite the increase in reports to vaccine safety monitoring systems, COVID-19 vaccines are safe and undergo rigorous testing. VAERS and other systems help detect potential safety issues but do not confirm causation. The surge in reports is due to a large number of doses and increased reporting requirements.